Skip to main content
NCBI home page
Redox Report : Communications in Free Radical Research logoLink to Redox Report : Communications in Free Radical Research
. 2013 Jul 19;15(4):146–154. doi: 10.1179/174329210X12650506623762

Role of glutathione in augmenting the anticancer activity of pyrroloquinoline quinone (PQQ)

Bhavani S Shankar 1, Ruchi Pandey 1, Prayag Amin 1, Hari S Misra 2, Krishna B Sainis 3
PMCID: PMC7067314  PMID: 20663290

Abstract

Pyrroloquinoline quinone (PQQ), a bacterial redox co-factor and antioxidant, is highly reactive with nucleophilic compounds present in biological fluids. PQQ induced apoptosis in human promonocytic leukemia U937 cells and this was accompanied by depletion of the major cellular antioxidant glutathione and increase in intracellular reactive oxygen species (ROS). Treatment with glutathione (GSH) or N-acetyl-L-cysteine (NAC) did not spare PQQ toxicity but resulted in a 2–5-fold increase in PQQ-induced apoptosis in U937 cells. Cellular GSH levels increased following treatment by NAC alone but were severely depleted by co-treatment with NAC and PQQ. This was accompanied by an increase in intracellular ROS. Alternatively, depletion of glutathione also resulted in increased PQQ cytotoxicity. However, the cells underwent necrosis as evidenced by dual labeling with annexin V and propidium iodide. PQQ-induced cytotoxicity is thus critically regulated by the cellular redox status. An increase in GSH can augment apoptosis and its depletion can switch the mode of cell death to necrosis in the presence of PQQ. Our data suggest that modulation of intracellular GSH can be used as an effective strategy to potentiate cytotoxicity of quinones like PQQ.

Keywords: PYRROLOQUINOLINE QUINONE, PQQ, PRO-OXIDANT, APOPTOSIS, NECROSIS, GLUTATHIONE

Full Text

The Full Text of this article is available as a PDF (465.5 KB).

References

  • 1.Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 1999; 26: 107–116. [DOI] [PubMed] [Google Scholar]
  • 2.Boots AW, Kubben N, Haenen GR, Bast A. Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation. Biochem Biophys Res Commun 2003; 308: 560–565. [DOI] [PubMed] [Google Scholar]
  • 3.Boots AW, Li H, Schins RP et al. The quercetin paradox. Toxicol Appl Pharmacol 2007; 222: 89–96. [DOI] [PubMed] [Google Scholar]
  • 4.Chung SH, Chung SM, Lee JY, Kim SR, Park KS, Chung JH. The biological significance of non-enzymatic reaction of menadione with plasma thiols: enhancement of menadione-induced cytotoxicity to platelets by the presence of blood plasma. FEBS Lett 1999; 449: 235–240. [DOI] [PubMed] [Google Scholar]
  • 5.Monks TJ, Jones DC. The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. Curr Drug Metab 2002; 3: 425–438. [DOI] [PubMed] [Google Scholar]
  • 6.Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. Role of quinones in toxicology. Chem Res Toxicol 2000; 13: 135–160. [DOI] [PubMed] [Google Scholar]
  • 7.Salisbury SA, Forrest HS, Cruse WB, Kennard O. A novel coenzyme from bacterial primary alcohol dehydrogenases. Nature 1979; 280: 843–844. [DOI] [PubMed] [Google Scholar]
  • 8.Fluckiger R, Paz M, Mah J, Bishop A, Gallop PM. Characterization of the glycine-dependent redox-cycling activity in animal fluids and tissues using specific inhibitors and activators: evidence for presence of PQQ. Biochem Biophys Res Commun 1993; 196: 61–68. [DOI] [PubMed] [Google Scholar]
  • 9.Aizenman E, Hartnett KA, Zhong C, Gallop PM, Rosenberg PA. Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox modulatory site. J Neurosci 1992; 12: 2362–2369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zhang Y, Rosenberg PA. The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formation. Eur J Neurosci 2002; 16: 1015–1024. [DOI] [PubMed] [Google Scholar]
  • 11.Miyauchi K, Urakami T, Abeta H, Shi H, Noguchi N, Niki E. Action of pyrroloquinolinequinol as an antioxidant against lipid peroxidation in solution. Antioxid Redox Signal 1999; 1: 547–554. [DOI] [PubMed] [Google Scholar]
  • 12.He K, Nukada H, Urakami T, Murphy MP. Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem Pharmacol 2003; 65: 67–74. [DOI] [PubMed] [Google Scholar]
  • 13.Hirakawa A, Shimizu K, Fukumitsu H, Furukawa S. Pyrroloquinoline quinone attenuates iNOS gene expression in the injured spinal cord. Biochem Biophys Res Commun 2009; 378: 308–312. [DOI] [PubMed] [Google Scholar]
  • 14.Zhu BQ, Simonis U, Cecchini G et al. Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther 2006; 11: 119–128. [DOI] [PubMed] [Google Scholar]
  • 15.Sato K, Toriyama M. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma. J Dermatol Sci 2009; 53: 140–145. [DOI] [PubMed] [Google Scholar]
  • 16.Kosano H, Setogawa T, Kobayashi K, Nishigori H. Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by alpha-melanocyte stimulating hormone in murine B16 melanoma cells. Life Sci 1995; 56: 1707–1713. [DOI] [PubMed] [Google Scholar]
  • 17.Adachi O, Okamoto K, Shinagawa E, Matsushita K, Ameyama M. Adduct formation of pyrroloquinoline quinone and amino acid. Biofactors 1988; 1: 251–254. [PubMed] [Google Scholar]
  • 18.Shankar B, Kumar SS, Sainis KB. Generation of reactive oxygen species and radiation response in lymphocytes and tumor cells. Radiat Res 2003; 160: 478–487. [DOI] [PubMed] [Google Scholar]
  • 19.Myhre O, Andersen JM, Aarnes H, Fonnum E Evaluation of the probes 2',7'-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem Pharmacol 2003; 65: 1575–1582. [DOI] [PubMed] [Google Scholar]
  • 20.Kosower EM, Kosower NS. Bromobimane probes for thiols. Methods Enzymol 1995; 251: 133–148. [DOI] [PubMed] [Google Scholar]
  • 21.Rice GC, Bump EA, Shrieve DC, Lee W, Kovacs M. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res 1986; 46: 6105–6110. [PubMed] [Google Scholar]
  • 22.Shankar B, Premachandran S, Bharambe SD, Sundaresan P, Sainis KB. Modification of immune response by low dose ionizing radiation: role of apoptosis. Immunol Lett 1999; 68: 237–245. [DOI] [PubMed] [Google Scholar]
  • 23.Ghibelli L, Coppola S, Fanelli C et al. Glutathione depletion causes cytochrome c release even in the absence of cell commitment to apoptosis. FASEB J1999; 13: 2031-2036. [DOI] [PubMed] [Google Scholar]
  • 24.Kumazawa T, Hiwasa T, Takiguchi M, Suzuki O, Sato K. Activation of Ras signaling pathways by pyrroloquinoline quinone in NIH3T3 mouse fibroblasts. Int .1 Mol Med 2007; 19: 765–770. [PubMed] [Google Scholar]
  • 25.Tibodeau J, Benson L, Isham C, Owen W, Bible K. The Anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase. Antioxid Redox Signal 2009; 11: 1097–1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Madan E, Prasad S, Roy P, George J, Shukla Y Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells. Biochem Biophys Res Commun 2008; 377: 1232–1237. [DOI] [PubMed] [Google Scholar]
  • 27.Liu Z, Huang SL, Li MM, Huang ZS, Lee KS, Gu LQ. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity. Chem Biol Interact 2009; 177: 48–57. [DOI] [PubMed] [Google Scholar]
  • 28.Chiou TJ, Chu ST, Tzeng WF. Protection of cells from menadione-induced apoptosis by inhibition of lipid peroxidation. Toxicology 2003; 191: 77–88. [DOI] [PubMed] [Google Scholar]
  • 29.O'Brien PJ. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact 1991; 80: 1–41. [DOI] [PubMed] [Google Scholar]
  • 30.Verrax J, Delvaux M, Beghein N, Taper H, Gallez B, Buc Calderon P. Enhancement of quinone redox cycling by ascorbate induces a caspase-3 independent cell death in human leukaemia cells. An in vitro comparative study. Free Radic Res 2005; 39: 649–657. [DOI] [PubMed] [Google Scholar]
  • 31.Piga R, Saito Y, Yoshida Y, Niki E. Cytotoxic effects of various stressors on PC12 cells: involvement of oxidative stress and effect of antioxidants. Neurotoxicology 2007; 28: 67–75. [DOI] [PubMed] [Google Scholar]
  • 32.Thornton DE, Jones KH, Jiang Z, Zhang H, Liu G, Cornwell DG. Antioxidant and cytotoxic tocopheryl quinones in normal and cancer cells. Free Radic Biol Med 1995; 18: 963–976. [DOI] [PubMed] [Google Scholar]
  • 33.Wang D, Wei Y, Sclunoll D, Maclean KN, Pagliassotti MJ. Endoplasmic reticulum stress increases glucose-6-phosphatase and glucose cycling in liver cells. Endocrinology 2006; 147: 350–358. [DOI] [PubMed] [Google Scholar]
  • 34.Han YH, Kim SZ, Kim SH, Park WH. Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels. Lung Cancer 2008; 59: 301–314. [DOI] [PubMed] [Google Scholar]
  • 35.Naoi M, Yi H, Maruyama W et al. Glutathione redox status in mitochondria and cytoplasm differentially and sequentially activates apoptosis cascade in dopamine-melanin treated SH-SY5Y cells. Neurosci Lett 2009; 465: 118–122. [DOI] [PubMed] [Google Scholar]
  • 36.Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG, Nussler AK. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 2000; 89: 1440–1447. [PubMed] [Google Scholar]

Articles from Redox Report : Communications in Free Radical Research are provided here courtesy of Taylor & Francis

RESOURCES